Eric Burak's most recent trade in Fusion Pharmaceuticals Inc was a trade of 106,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fusion Pharmaceuticals Inc | Burak Eric | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 106,100 | 106,100 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Burak Eric | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 63,700 | 63,700 | - | - | Restricted Stock Units | |
| Fusion Pharmaceuticals Inc | Eric Burak | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Eric Burak | Chief? Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 168,200 | 168,200 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Eric Burak | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 139,000 | 139,000 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Eric Burak | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 136,600 | 136,600 | - | - | Stock Option (Right to Buy) | |
| Fusion Pharmaceuticals Inc | Eric Burak | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2021 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) |